Literature DB >> 14512561

Herpes simplex virus type 2 induces rapid cell death and functional impairment of murine dendritic cells in vitro.

C A Jones1, M Fernandez, K Herc, L Bosnjak, M Miranda-Saksena, R A Boadle, A Cunningham.   

Abstract

Dendritic cells (DC) are critical for stimulation of naive T cells. Little is known about the effect of herpes simplex virus type 2 (HSV-2) infection on DC structure or function or if the observed effects of HSV-1 on human DC are reproduced in murine DC. Here, we demonstrate that by 12 h postinfection, wild-type (wt) HSV-2 (186) abortively infected murine bone marrow-derived DC and induced early cell death compared to UV-inactivated HSV-2 or mock-infected DC. HSV-2-induced loss of DC viability was more rapid than that induced by HSV-1 and was due, in part, to apoptosis, as shown by TEM, caspase-3 activation, and terminal deoxynucleotidyl transferase-mediated dCTP biotin nick end labeling. HSV induced type-specific changes in the murine DC immunophenotype. At 12 h postinfection, wt HSV-2 upregulated DC major histocompatibility complex (MHC) class II expression, and in contrast to UV-inactivated HSV-2, downregulated expression of MHC class I, but it had no effect on surface CD40, CD80, or CD86. Wt HSV-1 (MC-1) induced only CD40 upregulation. More-profound effects on the DC immunophenotype were observed in HSV-2-infected neonatal DC. Wt HSV of either serotype impaired murine DC-induced T-cell alloproliferation and lipopolysaccharide-induced DC interleukin-12 secretion. Thus, there are marked differences in the levels of HSV-induced cytolysis in DC according to the HSV serotype, although HSV-2 displays immunomodulatory effects on the DC immunophenotype and function similar to those of HSV-1.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14512561      PMCID: PMC224953          DOI: 10.1128/jvi.77.20.11139-11149.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Regions of the herpes simplex virus type 1 latency-associated transcript that protect cells from apoptosis in vitro and protect neuronal cells in vivo.

Authors:  Maryam Ahmed; Martin Lock; Cathie G Miller; Nigel W Fraser
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

2.  Inhibition of apoptosis by primary isolates of herpes simplex virus.

Authors:  K R Jerome; R Fox; Z Chen; P Sarkar; L Corey
Journal:  Arch Virol       Date:  2001       Impact factor: 2.574

Review 3.  How dendritic cells and microbes interact to elicit or subvert protective immune responses.

Authors:  Karolina Palucka; Jacques Banchereau
Journal:  Curr Opin Immunol       Date:  2002-08       Impact factor: 7.486

4.  Immature monocyte-derived dendritic cells are productively infected with herpes simplex virus type 1.

Authors:  Z Mikloska; L Bosnjak; A L Cunningham
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

5.  T lymphocytes potentiate murine dendritic cells to produce IL-12.

Authors:  Alexandra Rizzitelli; Rolande Berthier; Véronique Collin; Serge M Candéias; Patrice N Marche
Journal:  J Immunol       Date:  2002-10-15       Impact factor: 5.422

6.  Dendritic cell vaccination protects mice against lethality caused by genital herpes simplex virus type 2 infection.

Authors:  E Schön; A M Harandi; I Nordström; J Holmgren; K Eriksson
Journal:  J Reprod Immunol       Date:  2001-05       Impact factor: 4.054

7.  The herpes simplex virus type 2 R1 protein kinase (ICP10 PK) blocks apoptosis in hippocampal neurons, involving activation of the MEK/MAPK survival pathway.

Authors:  D Perkins; E F R Pereira; M Gober; P J Yarowsky; L Aurelian
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

8.  Maternal immunization with a herpes simplex virus type 2 replication-defective virus reduces visceral dissemination but not lethal encephalitis in newborn mice after oral challenge.

Authors:  Ingrid A C Evans; Cheryl A Jones
Journal:  J Infect Dis       Date:  2002-05-17       Impact factor: 5.226

9.  Herpes simplex virus type 1 infection prevents detachment of nerve growth factor-differentiated PC12 cells in culture.

Authors:  Michael J Moxley; Timothy M Block; Hsi-Chou Liu; Nigel W Fraser; Guey-Chuen Perng; Steven L Wechsler; Ying-Hsiu Su
Journal:  J Gen Virol       Date:  2002-07       Impact factor: 3.891

10.  Rapid cytotoxic T lymphocyte activation occurs in the draining lymph nodes after cutaneous herpes simplex virus infection as a result of early antigen presentation and not the presence of virus.

Authors:  Scott N Mueller; Claerwen M Jones; Chris M Smith; William R Heath; Francis R Carbone
Journal:  J Exp Med       Date:  2002-03-04       Impact factor: 14.307

View more
  44 in total

1.  Activation of NF-κB in CD8+ dendritic cells Ex Vivo by the γ134.5 null mutant correlates with immunity against herpes simplex virus 1.

Authors:  Huali Jin; Yijie Ma; Zhipeng Yan; Bellur S Prabhakar; Bin He
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

Review 2.  Dancing with the enemy: the interplay of herpes simplex virus with dendritic cells.

Authors:  N Novak; W M Peng
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

Review 3.  Herpesvirus interference with major histocompatibility complex class II-restricted T-cell activation.

Authors:  Emmanuel J Wiertz; Robert Devlin; Helen L Collins; Maaike E Ressing
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

Review 4.  Antigen presentation by monocytes and monocyte-derived cells.

Authors:  Gwendalyn J Randolph; Claudia Jakubzick; Chunfeng Qu
Journal:  Curr Opin Immunol       Date:  2007-12-21       Impact factor: 7.486

5.  Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells.

Authors:  Sammy Bedoui; Paul G Whitney; Jason Waithman; Liv Eidsmo; Linda Wakim; Irina Caminschi; Rhys S Allan; Magdalena Wojtasiak; Ken Shortman; Francis R Carbone; Andrew G Brooks; William R Heath
Journal:  Nat Immunol       Date:  2009-04-06       Impact factor: 25.606

6.  The gamma 1 34.5 protein of herpes simplex virus 1 is required to interfere with dendritic cell maturation during productive infection.

Authors:  Huali Jin; Yijie Ma; Bellur S Prabhakar; Zongdi Feng; Tibor Valyi-Nagy; Zhipeng Yan; Dustin Verpooten; Cuizhu Zhang; Youjia Cao; Bin He
Journal:  J Virol       Date:  2009-03-11       Impact factor: 5.103

Review 7.  Keeping it in check: chronic viral infection and antiviral immunity in the brain.

Authors:  Katelyn D Miller; Matthias J Schnell; Glenn F Rall
Journal:  Nat Rev Neurosci       Date:  2016-11-04       Impact factor: 34.870

8.  Role for plasmacytoid dendritic cells in the immune control of recurrent human herpes simplex virus infection.

Authors:  Heather Donaghy; Lidija Bosnjak; Andrew N Harman; Valerie Marsden; Stephen K Tyring; Tze-Chiang Meng; Anthony L Cunningham
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

9.  Pathogenesis of neonatal herpes simplex 2 disease in a mouse model is dependent on entry receptor expression and route of inoculation.

Authors:  Sarah J Kopp; Andrew H Karaba; Laura K Cohen; Ghazal Banisadr; Richard J Miller; William J Muller
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

10.  A role for plasmacytoid dendritic cells in the rapid IL-18-dependent activation of NK cells following HSV-1 infection.

Authors:  Daniel P Barr; Gabrielle T Belz; Patrick C Reading; Magdalena Wojtasiak; Paul G Whitney; William R Heath; Francis R Carbone; Andrew G Brooks
Journal:  Eur J Immunol       Date:  2007-05       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.